Jason Laine

CBD Gummies Gain Momentum in the Wellness Market 0
- CANNABIS OIL
- May 14, 2026
CBD gummies are rapidly emerging as a popular wellness product, offering a discreet and easy way to consume cannabidiol. Derived from hemp and free from psychoactive effects, these chewable supplements are commonly used to support sleep, stress relief, and recovery. Low-dose CBD products are available over the counter, provided they meet strict standards, including zero
READ MORE
Bohacek Drafts 2027 Bill To Legalize Medical Marijuana In Indiana 0
- MEDICAL MARIJUANA
- May 12, 2026
Indiana State Sen. Mike Bohacek is preparing 2027 legislation that would legalize medical marijuana, citing shifting federal policy and growing openness from Gov. Mike Braun. The proposal follows the Trump administration’s move to reclassify state-licensed medical marijuana as a less-restricted Schedule III drug, a change that recognizes its medical use under federal law. Bohacek’s measure
READ MORE

Medical Marijuana Shift Brings Big Stakes for the Midwest 0
- MEDICAL MARIJUANA
- May 6, 2026
The Trump administration’s decision to reclassify medical marijuana from Schedule I to Schedule III could quietly remake the Midwest cannabis landscape, even as prohibition holds firm in states like Wisconsin. The federal move leaves recreational marijuana untouched but opens the door for medical operators to access tax deductions, federal credits, and mainstream banking services that
READ MORE
Medical Marijuana Reclassified, But CBD Rules Largely Unchanged 0
- CANNABIS OIL
- May 5, 2026
Federal drug policy took a notable shift on April 23, when Acting U.S. Attorney General Todd Blanche ordered state-licensed medical marijuana moved from Schedule I to Schedule III, a category reserved for substances with “moderate to low” dependence risk. The change acknowledges growing public support for medical cannabis but stops short of altering federal rules
READ MORE